Description
In 2013 the Cochrane team, with the help of the BMJ’s open data campaign, was able to access full clinical study reports on neuraminidase inhibitors. Tom Jefferson and Peter Doshi explain what the new systematic review found and how a series of failures meant that decisions about these drugs were made without the full evidenceCitation
Jefferson, T. & Doshi, P. (2014). Multisystem failure: the story of anti-influenza drugs. BMJ 2014;348:g2263. DOI: https://doi.org/10.1136/bmj.g2263Keyword
neuraminidase inhibitorsclinical study reports
drug regulations
incomplete data
Influenza, Human--drug therapy
Antiviral Agents
Oseltamivir
Zanamivir
Identifier to cite or link to this item
http://hdl.handle.net/10713/6609ae974a485f413a2113503eed53cd6c53
10.1136/bmj.g2263
Scopus Count
Collections
Related articles
- [Multisystem failure: the story of antinfluenza drugs].
- Authors: Jefferson T, Doshi P
- Issue date: 2014 May
- Which agents should we use to treat and prevent influenza in 2006-2007?
- Authors: Mossad SB
- Issue date: 2006 Nov
- Antiviral drugs for influenza.
- Issue date: 2012 Jan 9
- Antiviral drugs for influenza.
- Issue date: 2008 Dec 15-29
- [Neuraminidase inhibitors: effects still unclear].
- Authors: Gillissen A
- Issue date: 2012 Oct